Opinions
Cameron Hurst
Align Technology Inc
ALGN-Q
DON'T BUY
Jun 08, 2018
$346.670
Stock price when the opinion was issued
Telecommunications
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
TOP PICK
Stockchase Research Editor: Michael O'Reilly During the pandemic, orthodontic services have been restricted. ALGN allows patients a safe, lower cost way, to achieve their goal for a better dental appearance. Patients work with orthodontists, but wear an aligner for their teeth that is not visible to others. Management just amped up their sales expectations to $3.7-$3.9 billion for the year, compared to analyst expectations of $3.49 billion. The company is expanding to include Europe, Japan and China. The company continues to build cash reserves, now estimated over $1.2 billion. We would buy this with a stop loss at $400, looking to achieve $707 -- upside potential over 25%. Yield 0% (Analysts’ price target is $707.00)
Telecommunications
PAST TOP PICK
(A Top Pick May 06/21, Up 0.95%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with ALGN has triggered its stop at $590. To remain disciplined, we recommend covering the balance of the position at this time. Combined with the previous recommendation to cover half the position, this results in a net investment return over 10%.
Telecommunications
STRONG BUY
Advertising
This falls into the medical device category, which he likes. The stock has gone parabolic and earnings beats have been great. It has a 50+ PE ratio. It will have to grow into that ratio before he would be buyer – needing at least 50% earnings growth.